Department of Pediatrics
-
March 7, 2019
Telemedicine holds promise for quick diagnosis of autism
Although increasing evidence shows that children with autism spectrum disorder (ASD) can be accurately identified during their second year of life, the average age of diagnosis in both Tennessee and across the country remains well above 4 years of age. -
February 14, 2019
Study finds children with autism more likely to face maltreatment
A recent study by Vanderbilt researchers of 11 counties in Middle Tennessee revealed that children with autism spectrum disorder (ASD) were nearly 2.5 times more likely than children without ASD to be reported to the Child Abuse Hotline by the age of 8. -
February 14, 2019
Patrick’s work lauded by Society for Pediatric Research
Stephen Patrick, MD, MPH, MS, has been named to receive the Society for Pediatric Research 2019 Young Investigator Award, an honor bestowed upon a young physician who has embarked on a career in investigative pediatrics. -
February 7, 2019
PheWAS Core helps researchers make sense of electronic health record data
Some biomedical researchers may be unsure about routine electronic health record (EHR) data and how useful it ultimately may prove for drawing meaningful, actionable associations that warrant changes to clinical practice and lead to improved clinical outcomes. -
February 7, 2019
‘A Campaign Against Childhood Cancer’ launched
Monroe Carell Jr. Children’s Hospital at Vanderbilt publicly launched a $15 million childhood cancer campaign this week. -
January 29, 2019
Long-term unemployment linked to increase in babies born with drug withdrawal
Babies born after being exposed to opioids before birth are more likely to be delivered in regions of the U.S. with high rates of long-term unemployment and lower levels of mental health services, according to a study from researchers at Vanderbilt University Medical Center and the RAND Corporation. -
January 28, 2019
Nasal whooping cough vaccine trial underway at Vanderbilt
Vanderbilt vaccine researchers are enrolling adult volunteers in a National Institutes of Health (NIH)-sponsored Phase II clinical trial that will study a next generation pertussis vaccine that may protect people from whooping cough.